Evidence map›Paper›PMID 26469251›Full record

ArticleJournal of neuropathology and experimental neurology2015

Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.

Brigid K Jensen, Hubert Monnerie, Maggie V Mannell, Patrick J Gannon, Cagla Akay Espinoza, Michelle A Erickson, Annadora J Bruce-Keller, Benjamin B Gelman, Lisa A Briand, R Christopher Pierce and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Dolutegravir induces endoplasmic reticulum stress at the blood-brain barrier.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Brigid K JensenFrom the Department of Neuroscience, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (BKJ, MVM); Department of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania (BKJ, HM, JBG); Department of Pathology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (BKJ, PJG, CAE, MAE, KLJ-S); Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana (AJB-K); Department of Pathology, University of Texas Medical Branch, Galveston, Texas (BBG) Department of Psychology, College of Liberal Arts, Temple University, Philadelphia, Pennsylvania (LAB); Center for Neurobiology and Behavior, Department of Psychiatry, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (CP).
Hubert Monnerie
Maggie V Mannell
Patrick J Gannon
Cagla Akay Espinoza
Michelle A Erickson
Annadora J Bruce-Keller
Benjamin B Gelman
Lisa A Briand
R Christopher Pierce
Kelly L Jordan-Sciutto
Judith B Grinspan
University of Pennsylvania · USChildren's Hospital of Philadelphia · USLouisiana State University System · USTemple University · USThe University of Texas Medical Branch at Galveston · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca A Simmons · 2006 to 2026
$35.3M
TRANSGENIC MOUSE MODELS OF MENTAL RETARDATIONP30HD026979 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBERTS, TIMOTHY P · 1990 to 2015
$15.3M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM008076 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A · 1985 to 2023
$10.8M
Oligodendrocyte damage and dysfunction in HIV associated neurocognitive disorderR01MH098742 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI JUDITH B GRINSPAN, Kelly L Jordan-Sciutto · 2012 to 2026
$9.0M
SYSTEMS AND INTEGRATIVE BIOLOGYT32GM007517 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI GOLD, JOSHUA I · 1985 to 2017
$8.0M
The Intellectual and Developmental Disabilities Research Center at CHOP/PennU54HD086984 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI PUTT, MARY E. · 2016 to 2020
$6.3M
Translational Research Training Program in Environmental Health SciencesT32ES019851 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Kara A Bernstein, Trevor M Penning · 2012 to 2026
$6.0M
TRAINING IN NEUROVIROLOGY AND NEUROIMMUNOLOGYT32NS007180 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 1985 to 2018
$2.8M
Novel Pathways of HAARTmediated Neuronal Toxicity in the Central Nervous SystemR01MH083517 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI JORDAN-SCIUTTO, KELLY L · 2009 to 2010
$1.0M
Effects of HIV- and ARV-Induced Oxidative Stress on Neuroglial CellsF31NS079192 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI JENSEN, BRIGID · 2013 to 2014
$71k
NIAID NIH HHS P30 AI045008NICHD NIH HHS HD26979NICHD NIH HHS P30 HD026979NICHD NIH HHS U54 HD086984NIEHS NIH HHS P30 ES013508NIEHS NIH HHS T32ES01985NIEHS NIH HHS T32 ES019851NIGMS NIH HHS T32 GM007517NIGMS NIH HHS T32 GM008076NIGMS NIH HHS T32GM7517-33NIMH NIH HHS R01 MH083517NIMH NIH HHS R01 MH098742NIMH NIH HHS U24 MH100930NINDS NIH HHS F31 NS079192NINDS NIH HHS F31NS079192-01A1NINDS NIH HHS T32 NS007180NINDS NIH HHS T32NS007180-29
6 · The paper itself

Abstract

Despite effective viral suppression through combined antiretroviral therapy (cART), approximately half of HIV-positive individuals have HIV-associated neurocognitive disorders (HAND). Studies of antiretroviral-treated patients have revealed persistent white matter abnormalities including diffuse myelin pallor, diminished white matter tracts, and decreased myelin protein mRNAs. Loss of myelin can contribute to neurocognitive dysfunction because the myelin membrane generated by oligodendrocytes is essential for rapid signal transduction and axonal maintenance. We hypothesized that myelin changes in HAND are partly due to effects of antiretroviral drugs on oligodendrocyte survival and/or maturation. We showed that primary mouse oligodendrocyte precursor cell cultures treated with therapeutic concentrations of HIV protease inhibitors ritonavir or lopinavir displayed dose-dependent decreases in oligodendrocyte maturation; however, this effect was rapidly reversed after drug removal. Conversely, nucleoside reverse transcriptase inhibitor zidovudine had no effect. Furthermore, in vivo ritonavir administration to adult mice reduced frontal cortex myelin protein levels. Finally, prefrontal cortex tissue from HIV-positive individuals with HAND on cART showed a significant decrease in myelin basic protein compared with untreated HIV-positive individuals with HAND or HIV-negative controls. These findings demonstrate that antiretrovirals can impact myelin integrity and have implications for myelination in juvenile HIV patients and myelin maintenance in adults on lifelong therapy.

Indexed as

HIV InfectionsAdultAnimalsAnimals, NewbornAntirheumatic AgentsCell DifferentiationCells, CulturedCognition DisordersCohort StudiesDisease Models, AnimalGangliosidesGene Expression Regulation, ViralHumansMaleMiceMice, Inbred C57BLAntirheumatic Agentsganglioside A2B5GangliosidesMyelin Basic ProteinMyelin Proteolipid ProteinPlp1 protein, mouseReactive Oxygen Species

Identifiers

PMID26469251
PMCPMC4608376
OpenAlexW2332670321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.